CLINICAL_TRIALS
trial_result
· 2022-07-01
Clinical Trial Update: Pazopanib and ARQ 197 for Advanced Solid Tumors [Phase 1]
Summary
Phase 1 trial update evaluating pazopanib and ARQ 197 in patients with advanced solid tumors; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2022-07-01